Brevibloc

Esmolol Hydrochloride (Brevibloc) is a beta-blocker used for intravenous administration. It is commonly used to manage rapid heart rates and control blood pressure during surgery. This medication is manufactured by Baxter SAS and is available in the EU.

Esmolol Hydrochloride is primarily used for the rapid control of heart rate and blood pressure. It is often administered intravenously to manage conditions such as supraventricular tachycardia and to control heart rate during surgery. This medication is designed to provide quick-acting effects, making it suitable for situations requiring immediate intervention.

Esmolol Hydrochloride works by blocking beta-adrenergic receptors, which helps to slow down the heart rate and reduce blood pressure. Common effects may include a decrease in heart rate and blood pressure, which can help manage certain cardiovascular conditions. The medication is known for its short duration of action, providing rapid onset and offset of effects.

Esmolol Hydrochloride should be used with caution in patients with certain heart conditions, such as heart block or severe heart failure. It is important to monitor heart rate and blood pressure closely during administration. Patients with asthma or other respiratory conditions should also use this medication with caution, as beta-blockers can affect breathing.

Esmolol Hydrochloride may interact with other medications that affect heart rate or blood pressure, including other beta-blockers, calcium channel blockers, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other sedatives should be discussed with a healthcare professional.